Amdocs Limited (NASDAQ:DOX) has received a consensus recommendation of “Hold” from the eight analysts that are currently covering the company, MarketBeat reports. Three analysts have rated the stock with a sell rating, three have assigned a hold rating and one has given a buy rating to the company. The average 1-year target price among brokerages that have issued a report on the stock in the last year is $74.00.
Several analysts recently weighed in on DOX shares. Zacks Investment Research downgraded Amdocs from a “hold” rating to a “sell” rating in a research note on Monday, November 26th. BidaskClub downgraded Amdocs from a “buy” rating to a “hold” rating in a research note on Wednesday, November 28th. JPMorgan Chase & Co. set a $70.00 price target on Amdocs and gave the stock a “hold” rating in a research note on Tuesday, December 11th. Finally, ValuEngine downgraded Amdocs from a “hold” rating to a “sell” rating in a research note on Friday, February 15th.
Shares of DOX stock traded down $1.20 during midday trading on Friday, reaching $53.83. 683,327 shares of the stock were exchanged, compared to its average volume of 1,071,746. Amdocs has a 1 year low of $52.60 and a 1 year high of $70.31. The company has a market capitalization of $7.51 billion, a price-to-earnings ratio of 14.39, a price-to-earnings-growth ratio of 1.65 and a beta of 0.52.
Amdocs (NASDAQ:DOX) last posted its earnings results on Tuesday, February 5th. The technology company reported $0.98 earnings per share for the quarter, missing analysts’ consensus estimates of $0.99 by ($0.01). Amdocs had a return on equity of 14.75% and a net margin of 8.46%. The firm had revenue of $1.01 billion for the quarter, compared to analysts’ expectations of $1.01 billion. During the same quarter last year, the company posted $1.06 EPS. The firm’s revenue was up 3.5% on a year-over-year basis. Research analysts forecast that Amdocs will post 3.92 earnings per share for the current year.
The business also recently declared a quarterly dividend, which will be paid on Friday, April 19th. Investors of record on Friday, March 29th will be paid a $0.285 dividend. The ex-dividend date is Thursday, March 28th. This represents a $1.14 annualized dividend and a dividend yield of 2.12%. This is an increase from Amdocs’s previous quarterly dividend of $0.25. Amdocs’s dividend payout ratio is presently 26.74%.
Hedge funds have recently added to or reduced their stakes in the stock. BTIM Corp. lifted its position in Amdocs by 8.3% in the 4th quarter. BTIM Corp. now owns 223,891 shares of the technology company’s stock valued at $13,115,000 after acquiring an additional 17,172 shares in the last quarter. Assenagon Asset Management S.A. bought a new position in Amdocs in the 4th quarter valued at approximately $756,000. Cutler Group LP bought a new position in Amdocs in the 4th quarter valued at approximately $55,000. Bank of Montreal Can lifted its holdings in shares of Amdocs by 7.7% during the 4th quarter. Bank of Montreal Can now owns 1,104,692 shares of the technology company’s stock valued at $64,714,000 after buying an additional 79,171 shares during the period. Finally, Cerebellum GP LLC lifted its holdings in shares of Amdocs by 49.2% during the 4th quarter. Cerebellum GP LLC now owns 4,295 shares of the technology company’s stock valued at $252,000 after buying an additional 1,417 shares during the period. 93.24% of the stock is currently owned by institutional investors and hedge funds.
Amdocs Limited, through its subsidiaries, provides software and services to the communications, pay TV, entertainment, and media industry service providers worldwide. The company offers amdocsONE a line of services designed for various stages of a service provider's lifecycle, including planning, delivery, implementation, and ongoing support, as well as consumer experience and monetization, media and digital, enterprise and connected society, service-driven network, and services and agile operation solutions.
Featured Story: How do investors use RSI to grade stocks?
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.